Analyst Conference Summaries

Biotechnology Investor Aids

Bristol-Myers Squibb
RETA

I Plan To Keep Bristol-Myers Squibb Stock Issued For Celgene [January 15, 2019 at Seeking Alpha

conference date: January 24, 2019 @ 5:30 A.M. Pacific Time

2019
 
 
 
January 24, 2019
 
 
 

Bristol-Myers Squibb (BMY) is a large-cap biotechnology and pharmaceutical company.

Bristol-Myers Squibb web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMD
 AMGN
 BIIB
 CLDX
 CELG
 EPZM
 GILD
 GLYC
 INO
 ISRG
 MCHP
 MYL.
 PLX
 REGN
 SGEN
 TTPH
 VBLT
 VSTM
 XLNX
 XLRN
 
 

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2019 William P. Meyers